| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.835 | 0.003 | 0.897 | P-glycoprotein inhibitor | 0.765 0.004 DBMET01573 0.897 0.002 DBMET01574 | DBMET01574 | |
| 0.792 | 0.018 | 0.797 | Apoptosis agonist | 0.797 0.017 DBMET01573 0.78 0.019 DBMET01574 | DBMET01573 | |
| 0.728 | 0.011 | 0.728 | Analgesic | 0.249 0.183 DBMET01573 0.306 0.137 DBMET01574 | ||
| 0.663 | 0.011 | 0.788 | Cholesterol antagonist | 0.788 0.004 DBMET01573 0.676 0.01 DBMET01574 | DBMET01573 | |
| 0.651 | 0.003 | 0.651 | Growth hormone agonist | 0.552 0.004 DBMET01573 0.636 0.003 DBMET01574 | ||
| 0.552 | 0.068 | 0.791 | Antiinflammatory | 0.577 0.06 DBMET01573 0.791 0.017 DBMET01574 | DBMET01574 | |
| 0.457 | 0.015 | 0.457 | Vasodilator | 0.396 0.024 DBMET01573 0.404 0.022 DBMET01574 | ||
| 0.447 | 0.012 | 0.447 | Calcium channel activator | 0.41 0.021 DBMET01573 0.41 0.021 DBMET01574 | ||
| 0.487 | 0.065 | 0.552 | Caspase 9 stimulant | 0.552 0.044 DBMET01573 0.551 0.045 DBMET01574 | DBMET01573 | |
| 0.448 | 0.044 | 0.448 | Toll-Like receptor agonist | |||
| 0.409 | 0.012 | 0.551 | Hepatoprotectant | 0.551 0.005 DBMET01573 0.318 0.025 DBMET01574 | DBMET01573 | |
| 0.381 | 0.014 | 0.381 | Platelet adhesion inhibitor | 0.203 0.069 DBMET01573 0.378 0.014 DBMET01574 | ||
| 0.418 | 0.069 | 0.57 | Antibacterial | 0.57 0.024 DBMET01573 0.473 0.049 DBMET01574 | DBMET01573 | |
| 0.376 | 0.028 | 0.53 | Nitric oxide antagonist | 0.424 0.023 DBMET01573 0.53 0.014 DBMET01574 | DBMET01574 | |
| 0.353 | 0.006 | 0.367 | Expectorant | 0.348 0.006 DBMET01573 0.367 0.005 DBMET01574 | DBMET01574 | |
| 0.408 | 0.062 | 0.607 | Transcription factor NF kappa B inhibitor | 0.591 0.032 DBMET01573 0.607 0.03 DBMET01574 | DBMET01574 | |
| 0.366 | 0.049 | 0.446 | Apoptosis antagonist | 0.295 0.089 DBMET01573 0.446 0.028 DBMET01574 | DBMET01574 | |
| 0.343 | 0.028 | 0.343 | 5 Hydroxytryptamine uptake stimulant | 0.279 0.057 DBMET01573 0.279 0.057 DBMET01574 | ||
| 0.4 | 0.101 | 0.4 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.31 | 0.017 | 0.392 | Lipid peroxidase inhibitor | 0.273 0.023 DBMET01573 0.392 0.01 DBMET01574 | DBMET01574 | |
| 0.305 | 0.017 | 0.335 | Neurotrophic factor enhancer | 0.335 0.011 DBMET01573 0.298 0.019 DBMET01574 | DBMET01573 | |
| 0.351 | 0.073 | 0.453 | Vasodilator, peripheral | 0.453 0.039 DBMET01573 0.439 0.044 DBMET01574 | DBMET01573 | |
| 0.296 | 0.022 | 0.451 | Lipocortins synthesis antagonist | 0.367 0.012 DBMET01573 0.451 0.005 DBMET01574 | DBMET01574 | |
| 0.269 | 0.004 | 0.321 | Adenylate cyclase stimulant | 0.317 0.002 DBMET01573 0.321 0.002 DBMET01574 | DBMET01574 | |
| 0.319 | 0.064 | 0.319 | 5 Hydroxytryptamine release stimulant | 0.204 0.118 DBMET01573 0.204 0.118 DBMET01574 | ||
| 0.266 | 0.014 | 0.266 | Protein-tyrosine phosphatase 1B inhibitor | 0.195 0.03 DBMET01573 0.229 0.021 DBMET01574 | ||
| 0.254 | 0.025 | 0.384 | Protein kinase stimulant | 0.384 0.009 DBMET01573 0.325 0.014 DBMET01574 | DBMET01573 | |
| 0.237 | 0.009 | 0.259 | Arachidonic acid antagonist | 0.256 0.005 DBMET01573 0.259 0.004 DBMET01574 | DBMET01574 | |
| 0.222 | 0.006 | 0.222 | Prolactin inhibitor | 0.168 0.016 DBMET01573 0.168 0.016 DBMET01574 | ||
| 0.319 | 0.104 | 0.319 | GABA C receptor rho-3 antagonist | |||
| 0.267 | 0.053 | 0.267 | Tyrosine 3 hydroxylase inhibitor | 0.205 0.126 DBMET01573 0.205 0.126 DBMET01574 | ||
| 0.279 | 0.065 | 0.297 | Cardiotonic | 0.297 0.058 DBMET01573 0.201 0.118 DBMET01574 | DBMET01573 | |
| 0.338 | 0.126 | 0.338 | 5 Hydroxytryptamine release inhibitor | 0.257 0.219 DBMET01573 0.257 0.219 DBMET01574 | ||
| 0.224 | 0.012 | 0.224 | CF transmembrane conductance regulator agonist | 0.218 0.014 DBMET01573 0.218 0.014 DBMET01574 | ||
| 0.243 | 0.033 | 0.243 | Protein-tyrosine phosphatase inhibitor | 0.163 0.067 DBMET01573 0.2 0.047 DBMET01574 | ||
| 0.233 | 0.026 | 0.311 | Alpha-N-acetylglucosaminidase inhibitor | 0.311 0.015 DBMET01573 0.311 0.015 DBMET01574 | DBMET01574 | |
| 0.209 | 0.004 | 0.209 | Estrogen receptor alpha agonist | 0.18 0.005 DBMET01573 0.061 0.015 DBMET01574 | ||
| 0.199 | 0.002 | 0.199 | Toll-Like receptor 4 agonist | 0.07 0.003 DBMET01573 0.07 0.003 DBMET01574 | ||
| 0.291 | 0.095 | 0.383 | Vasodilator, coronary | 0.383 0.041 DBMET01573 0.279 0.106 DBMET01574 | DBMET01573 | |
| 0.275 | 0.08 | 0.326 | Hypoxia-inducible factor 1 alpha inhibitor | 0.299 0.066 DBMET01573 0.326 0.054 DBMET01574 | DBMET01574 | |
| 0.219 | 0.031 | 0.475 | Interleukin 6 antagonist | 0.248 0.023 DBMET01573 0.475 0.005 DBMET01574 | DBMET01574 | |
| 0.19 | 0.004 | 0.196 | Ca2+-transporting ATPase inhibitor | 0.196 0.004 DBMET01573 0.196 0.004 DBMET01574 | DBMET01574 | |
| 0.251 | 0.066 | 0.316 | DNA synthesis inhibitor | 0.303 0.042 DBMET01573 0.316 0.039 DBMET01574 | DBMET01574 | |
| 0.198 | 0.021 | 0.315 | Antineoplastic antibiotic | 0.315 0.009 DBMET01573 0.264 0.013 DBMET01574 | DBMET01573 | |
| 0.214 | 0.043 | 0.214 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.174 | 0.005 | 0.174 | Estrogen receptor beta agonist | 0.166 0.006 DBMET01573 0.048 0.02 DBMET01574 | ||
| 0.194 | 0.027 | 0.276 | Adenylate cyclase inhibitor | 0.224 0.022 DBMET01573 0.276 0.016 DBMET01574 | DBMET01574 | |
| 0.173 | 0.012 | 0.173 | Thioredoxin inhibitor | 0.143 0.019 DBMET01573 0.156 0.015 DBMET01574 | ||
| 0.17 | 0.01 | 0.188 | Anabolic | 0.188 0.006 DBMET01573 0.188 0.005 DBMET01574 | DBMET01574 | |
| 0.194 | 0.034 | 0.194 | Anesthetic local | 0.156 0.046 DBMET01573 0.128 0.061 DBMET01574 | ||
| 0.227 | 0.067 | 0.231 | RNA-directed DNA polymerase inhibitor | 0.231 0.063 DBMET01573 0.231 0.063 DBMET01574 | DBMET01574 | |
| 0.178 | 0.025 | 0.178 | Beta amyloid protein antagonist | 0.132 0.056 DBMET01573 0.131 0.056 DBMET01574 | ||
| 0.178 | 0.03 | 0.237 | Farnesoid X receptor antagonist | 0.237 0.014 DBMET01573 0.231 0.014 DBMET01574 | DBMET01573 | |
| 0.174 | 0.026 | 0.174 | GABA C receptor agonist | 0.114 0.054 DBMET01573 0.114 0.054 DBMET01574 | ||
| 0.171 | 0.028 | 0.245 | Microtubule formation inhibitor | 0.245 0.01 DBMET01573 0.211 0.017 DBMET01574 | DBMET01573 | |
| 0.189 | 0.051 | 0.189 | Cholinergic | |||
| 0.19 | 0.052 | 0.26 | Phospholipase C inhibitor | 0.26 0.023 DBMET01573 0.256 0.024 DBMET01574 | DBMET01573 | |
| 0.146 | 0.009 | 0.146 | HIV-1 integrase inhibitor | 0.116 0.017 DBMET01574 | ||
| 0.308 | 0.171 | 0.308 | MAP kinase 1 inhibitor | |||
| 0.143 | 0.007 | 0.16 | Na+ K+ transporting ATPase inhibitor | 0.16 0.004 DBMET01573 0.16 0.004 DBMET01574 | DBMET01574 | |
| 0.225 | 0.092 | 0.225 | Aldehyde oxidase inhibitor | 0.197 0.106 DBMET01573 0.197 0.106 DBMET01574 | ||
| 0.171 | 0.044 | 0.171 | Acetylcholinesterase inhibitor | |||
| 0.184 | 0.063 | 0.184 | Succinate dehydrogenase inhibitor | 0.149 0.114 DBMET01573 0.149 0.114 DBMET01574 | ||
| 0.124 | 0.003 | 0.126 | Adenylate cyclase 1 inhibitor | 0.126 0.003 DBMET01573 0.126 0.003 DBMET01574 | DBMET01574 | |
| 0.173 | 0.055 | 0.231 | Interferon gamma antagonist | 0.189 0.045 DBMET01573 0.231 0.032 DBMET01574 | DBMET01574 | |
| 0.246 | 0.132 | 0.452 | Sodium/bile acid cotransporter inhibitor | 0.415 0.013 DBMET01573 0.452 0.007 DBMET01574 | DBMET01574 | |
| 0.197 | 0.086 | 0.359 | Antimitotic | 0.359 0.03 DBMET01573 | DBMET01573 | |
| 0.191 | 0.08 | 0.261 | Anesthetic general | 0.261 0.045 DBMET01573 0.186 0.083 DBMET01574 | DBMET01573 | |
| 0.169 | 0.06 | 0.188 | Melanin inhibitor | 0.188 0.047 DBMET01573 0.188 0.047 DBMET01574 | DBMET01574 | |
| 0.15 | 0.045 | 0.212 | Cholesterol synthesis inhibitor | 0.212 0.024 DBMET01573 0.206 0.025 DBMET01574 | DBMET01573 | |
| 0.139 | 0.037 | 0.139 | GABA C receptor antagonist | |||
| 0.124 | 0.023 | 0.124 | Ornithine decarboxylase inhibitor | 0.113 0.031 DBMET01573 0.113 0.031 DBMET01574 | ||
| 0.128 | 0.029 | 0.219 | Androgen antagonist | 0.2 0.014 DBMET01573 0.219 0.012 DBMET01574 | DBMET01574 | |
| 0.106 | 0.008 | 0.119 | Glutamate (mGluR6) antagonist | 0.117 0.006 DBMET01573 0.119 0.005 DBMET01574 | DBMET01574 | |
| 0.186 | 0.088 | 0.186 | Psychostimulant | |||
| 0.107 | 0.017 | 0.118 | Glycine receptor agonist | 0.118 0.013 DBMET01573 0.118 0.013 DBMET01574 | DBMET01574 | |
| 0.092 | 0.003 | 0.092 | Tubulin agonist | 0.085 0.003 DBMET01573 0.085 0.003 DBMET01574 | ||
| 0.166 | 0.077 | 0.18 | ATPase inhibitor | 0.18 0.057 DBMET01573 0.161 0.083 DBMET01574 | DBMET01573 | |
| 0.21 | 0.122 | 0.21 | Transcription factor STAT3 inhibitor | 0.185 0.156 DBMET01573 0.189 0.15 DBMET01574 | ||
| 0.115 | 0.029 | 0.115 | Phosphodiesterase 6D inhibitor | 0.103 0.047 DBMET01574 | ||
| 0.108 | 0.026 | 0.134 | Glycine receptor antagonist | 0.134 0.012 DBMET01573 0.134 0.012 DBMET01574 | DBMET01574 | |
| 0.099 | 0.017 | 0.138 | Estrogen agonist | 0.138 0.012 DBMET01573 0.054 0.033 DBMET01574 | DBMET01573 | |
| 0.129 | 0.048 | 0.129 | TRPA1 agonist | |||
| 0.189 | 0.109 | 0.189 | Nitric-oxide synthase stimulant | 0.184 0.118 DBMET01573 0.184 0.118 DBMET01574 | ||
| 0.135 | 0.055 | 0.135 | Proteasome inhibitor | 0.096 0.093 DBMET01573 | ||
| 0.143 | 0.067 | 0.146 | Pregnane X receptor agonist | 0.146 0.06 DBMET01573 0.128 0.105 DBMET01574 | DBMET01573 | |
| 0.105 | 0.03 | 0.136 | Phosphofructokinase-1 inhibitor | 0.136 0.021 DBMET01573 0.136 0.021 DBMET01574 | DBMET01574 | |
| 0.21 | 0.135 | 0.21 | Gastrin inhibitor | 0.184 0.174 DBMET01573 0.198 0.152 DBMET01574 | ||
| 0.115 | 0.042 | 0.115 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.113 0.044 DBMET01573 0.113 0.044 DBMET01574 | ||
| 0.15 | 0.078 | 0.15 | Peroxidase inhibitor | |||
| 0.191 | 0.121 | 0.373 | Antioxidant | 0.3 0.062 DBMET01573 0.373 0.04 DBMET01574 | DBMET01574 | |
| 0.077 | 0.008 | 0.077 | Pregnane X receptor antagonist | 0.076 0.009 DBMET01573 0.068 0.017 DBMET01574 | ||
| 0.086 | 0.021 | 0.113 | Androgen agonist | 0.112 0.011 DBMET01573 0.113 0.011 DBMET01574 | DBMET01574 | |
| 0.118 | 0.055 | 0.118 | Ferrochelatase inhibitor | |||
| 0.075 | 0.013 | 0.144 | Acetyl-CoA transferase 2 inhibitor | 0.144 0.003 DBMET01573 0.07 0.018 DBMET01574 | DBMET01573 | |
| 0.105 | 0.043 | 0.113 | Triose-phosphate isomerase inhibitor | 0.113 0.037 DBMET01573 0.113 0.037 DBMET01574 | DBMET01574 | |
| 0.187 | 0.128 | 0.266 | Immunostimulant | 0.257 0.093 DBMET01573 0.266 0.09 DBMET01574 | DBMET01574 | |
| 0.083 | 0.027 | 0.102 | Carbamoyl phosphate synthetase inhibitor | 0.102 0.02 DBMET01573 0.102 0.02 DBMET01574 | DBMET01574 | |
| 0.127 | 0.072 | 0.127 | Vanilloid 1 agonist | 0.116 0.099 DBMET01573 0.116 0.099 DBMET01574 | ||
| 0.107 | 0.053 | 0.133 | UDP-glucose 4-epimerase inhibitor | 0.133 0.036 DBMET01573 0.133 0.036 DBMET01574 | DBMET01574 | |
| 0.073 | 0.019 | 0.106 | Lipocortins synthesis agonist | 0.086 0.01 DBMET01573 0.106 0.004 DBMET01574 | DBMET01574 | |
| 0.068 | 0.015 | 0.068 | Aldosterone antagonist | 0.045 0.038 DBMET01573 0.06 0.019 DBMET01574 | ||
| 0.138 | 0.085 | 0.138 | Heat shock protein 70 antagonist | 0.131 0.115 DBMET01573 0.131 0.115 DBMET01574 | ||
| 0.108 | 0.055 | 0.124 | Adenylate kinase inhibitor | 0.124 0.041 DBMET01573 0.124 0.041 DBMET01574 | DBMET01574 | |
| 0.063 | 0.011 | 0.067 | Microtubule stabilization | 0.067 0.008 DBMET01573 0.065 0.01 DBMET01574 | DBMET01573 | |
| 0.062 | 0.017 | 0.074 | Glucose-6-phosphate isomerase inhibitor | 0.074 0.011 DBMET01573 0.074 0.011 DBMET01574 | DBMET01574 | |
| 0.076 | 0.033 | 0.076 | Glutamate (mGluR7) antagonist | 0.063 0.058 DBMET01573 | ||
| 0.099 | 0.057 | 0.11 | Lanosterol 14 alpha demethylase inhibitor | 0.11 0.042 DBMET01573 0.093 0.066 DBMET01574 | DBMET01573 | |
| 0.05 | 0.008 | 0.072 | Vanilloid 3 antagonist | 0.072 0.004 DBMET01573 0.046 0.013 DBMET01574 | DBMET01573 | |
| 0.073 | 0.032 | 0.074 | Aromatase inhibitor | 0.074 0.031 DBMET01573 0.061 0.04 DBMET01574 | DBMET01573 | |
| 0.087 | 0.047 | 0.087 | Estrogen-related receptor beta agonist | 0.085 0.052 DBMET01573 0.085 0.052 DBMET01574 | ||
| 0.09 | 0.05 | 0.117 | Transcription factor NF kappa B stimulant | 0.107 0.033 DBMET01573 0.117 0.027 DBMET01574 | DBMET01574 | |
| 0.084 | 0.046 | 0.084 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.091 | 0.055 | 0.105 | NADH dehydrogenase inhibitor | 0.105 0.039 DBMET01573 0.105 0.039 DBMET01574 | DBMET01574 | |
| 0.06 | 0.026 | 0.06 | Aconitate hydratase inhibitor | |||
| 0.063 | 0.029 | 0.08 | Protein 50S ribosomal subunit inhibitor | 0.08 0.019 DBMET01573 0.076 0.021 DBMET01574 | DBMET01573 | |
| 0.174 | 0.142 | 0.237 | Spasmolytic | 0.237 0.097 DBMET01573 0.165 0.15 DBMET01574 | DBMET01573 | |
| 0.078 | 0.047 | 0.086 | Glutamate dehydrogenase inhibitor | 0.086 0.039 DBMET01573 0.086 0.039 DBMET01574 | DBMET01574 | |
| 0.066 | 0.036 | 0.066 | Calcium channel P-type blocker | |||
| 0.103 | 0.073 | 0.103 | 5 Hydroxytryptamine 3A agonist | |||
| 0.108 | 0.078 | 0.188 | DNA polymerase I inhibitor | 0.188 0.032 DBMET01573 0.16 0.044 DBMET01574 | DBMET01573 | |
| 0.122 | 0.093 | 0.122 | Nav1.6 sodium channel blocker | |||
| 0.084 | 0.055 | 0.084 | Inducible nitric-oxide synthase inhibitor | |||
| 0.05 | 0.021 | 0.05 | Guanylate cyclase inhibitor | 0.043 0.029 DBMET01573 0.043 0.029 DBMET01574 | ||
| 0.114 | 0.085 | 0.114 | Cyclooxygenase 3 inhibitor | |||
| 0.031 | 0.003 | 0.042 | Telomerase stimulant | 0.042 0.002 DBMET01573 0.042 0.002 DBMET01574 | DBMET01574 | |
| 0.102 | 0.074 | 0.136 | Monophenol monooxygenase inhibitor | 0.136 0.053 DBMET01574 | DBMET01574 | |
| 0.034 | 0.008 | 0.042 | Hedgehog signaling activator | 0.042 0.004 DBMET01573 0.042 0.004 DBMET01574 | DBMET01574 | |
| 0.046 | 0.021 | 0.046 | Dopamine D5 agonist | |||
| 0.034 | 0.009 | 0.034 | Nicotinic acid receptor 2 antagonist | |||
| 0.053 | 0.028 | 0.053 | HCV NS3/NS4A protease inhibitor | 0.047 0.038 DBMET01573 | ||
| 0.061 | 0.036 | 0.071 | Argininosuccinate synthase inhibitor | 0.071 0.03 DBMET01573 0.071 0.03 DBMET01574 | DBMET01574 | |
| 0.04 | 0.017 | 0.058 | RNA-directed RNA polymerase stimulant | 0.058 0.011 DBMET01573 0.058 0.011 DBMET01574 | DBMET01574 | |
| 0.076 | 0.054 | 0.089 | Keratolytic | 0.089 0.039 DBMET01573 0.074 0.057 DBMET01574 | DBMET01573 | |
| 0.088 | 0.067 | 0.088 | Glutamate release inhibitor | |||
| 0.043 | 0.022 | 0.043 | Alpha 1d adrenoreceptor agonist | |||
| 0.083 | 0.062 | 0.083 | mTOR complex 2 inhibitor | |||
| 0.183 | 0.163 | 0.183 | Transcription factor STAT inhibitor | |||
| 0.03 | 0.01 | 0.03 | Vanilloid 2 agonist | 0.029 0.012 DBMET01573 0.029 0.012 DBMET01574 | ||
| 0.043 | 0.022 | 0.043 | GABA uptake inhibitor | |||
| 0.047 | 0.028 | 0.047 | Parathyroid hormone antagonist | 0.047 0.027 DBMET01573 0.047 0.027 DBMET01574 | ||
| 0.051 | 0.033 | 0.051 | Potassium channel (Inward rectifier) activator | 0.047 0.043 DBMET01573 | ||
| 0.049 | 0.031 | 0.049 | Cholesterol esterase inhibitor | |||
| 0.049 | 0.032 | 0.049 | Potassium channel (ATP-sensitive) activator | 0.045 0.041 DBMET01573 | ||
| 0.039 | 0.023 | 0.039 | Delayed rectifier potassium channel blocker | |||
| 0.039 | 0.024 | 0.039 | Retinoid X receptor antagonist | |||
| 0.042 | 0.027 | 0.042 | Kainate receptor agonist | 0.041 0.03 DBMET01573 0.041 0.03 DBMET01574 | ||
| 0.053 | 0.038 | 0.078 | Alpha-mannosidase inhibitor | 0.067 0.019 DBMET01573 0.078 0.012 DBMET01574 | DBMET01574 | |
| 0.053 | 0.039 | 0.058 | Acyl-CoA dehydrogenase inhibitor | 0.058 0.034 DBMET01573 0.058 0.034 DBMET01574 | DBMET01574 | |
| 0.084 | 0.07 | 0.084 | Potassium channel activator | |||
| 0.039 | 0.025 | 0.039 | Glutamate (mGluR8) agonist | |||
| 0.035 | 0.022 | 0.035 | Retinoid X alpha receptor antagonist | |||
| 0.03 | 0.017 | 0.036 | Purinergic P2Y15 antagonist | 0.036 0.01 DBMET01573 0.036 0.01 DBMET01574 | DBMET01574 | |
| 0.033 | 0.02 | 0.036 | Glutamate (mGluR3) agonist | 0.035 0.016 DBMET01573 0.036 0.015 DBMET01574 | DBMET01574 | |
| 0.125 | 0.112 | 0.125 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.072 | 0.059 | 0.072 | Vanilloid 4 agonist | |||
| 0.126 | 0.114 | 0.126 | GABA C receptor rho-2 antagonist | |||
| 0.082 | 0.071 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.088 | 0.078 | 0.088 | Electrolyte absorption antagonist | |||
| 0.051 | 0.042 | 0.051 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.089 | 0.08 | 0.089 | GABA C receptor rho-1 antagonist | |||
| 0.087 | 0.08 | 0.094 | Carbonic anhydrase III inhibitor | 0.089 0.077 DBMET01573 0.094 0.069 DBMET01574 | DBMET01574 | |
| 0.058 | 0.051 | 0.058 | Heme oxygenase stimulant | |||
| 0.065 | 0.059 | 0.065 | Secretase beta inhibitor | |||
| 0.075 | 0.068 | 0.075 | Calcium antagonist | |||
| 0.018 | 0.012 | 0.018 | Progesterone agonist | |||
| 0.097 | 0.092 | 0.153 | Alkylator | 0.153 0.045 DBMET01573 0.117 0.071 DBMET01574 | DBMET01573 | |
| 0.029 | 0.023 | 0.029 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.098 | 0.093 | 0.098 | Photosensitizer | |||
| 0.065 | 0.061 | 0.065 | Aminopeptidase I inhibitor | |||
| 0.065 | 0.061 | 0.065 | Epoxide hydrolase inhibitor | |||
| 0.096 | 0.093 | 0.096 | Electron transport complex I inhibitor | |||
| 0.036 | 0.033 | 0.036 | Membrane dipeptidase inhibitor | |||
| 0.05 | 0.048 | 0.063 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.063 0.031 DBMET01573 0.063 0.031 DBMET01574 | DBMET01574 | |
| 0.03 | 0.028 | 0.03 | Progesterone antagonist | |||
| 0.016 | 0.015 | 0.016 | Nicotinic acid receptor 1 antagonist | |||
| 0.03 | 0.029 | 0.035 | Fumarate hydratase inhibitor | 0.035 0.023 DBMET01573 0.035 0.023 DBMET01574 | DBMET01574 | |
| 0.023 | 0.025 | 0.031 | Sodium/glucose cotransporter 2 inhibitor | 0.031 0.012 DBMET01573 0.03 0.013 DBMET01574 | DBMET01573 | |
| 0.051 | 0.052 | 0.053 | Biliverdin reductase inhibitor | 0.053 0.049 DBMET01573 0.053 0.049 DBMET01574 | DBMET01574 | |
| 0.004 | 0.006 | 0.007 | Transcortin receptor antagonist | 0.007 0.004 DBMET01573 0.007 0.004 DBMET01574 | DBMET01574 | |
| 0.013 | 0.017 | 0.02 | Thromboxane A2 agonist | 0.02 0.006 DBMET01573 0.02 0.005 DBMET01574 | DBMET01574 | |
| 0.009 | 0.014 | 0.011 | Glutamate (mGluR6) agonist | 0.011 0.01 DBMET01574 | DBMET01574 | |
| 0.014 | 0.019 | 0.017 | Vitamin D receptor agonist | 0.017 0.01 DBMET01573 0.015 0.014 DBMET01574 | DBMET01573 | |
| 0.046 | 0.051 | 0.057 | Alcohol oxidase inhibitor | 0.057 0.038 DBMET01573 0.057 0.038 DBMET01574 | DBMET01574 | |
| 0.018 | 0.025 | 0.027 | Prostaglandin F2 alpha agonist | 0.023 0.015 DBMET01573 0.027 0.01 DBMET01574 | DBMET01574 | |
| 0.187 | 0.195 | 0.253 | Antithrombotic | 0.251 0.125 DBMET01573 0.253 0.124 DBMET01574 | DBMET01574 | |
| 0.022 | 0.031 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.016 DBMET01573 0.026 0.017 DBMET01574 | DBMET01573 | |
| 0.088 | 0.098 | 0.115 | Mucolytic | 0.109 0.066 DBMET01573 0.115 0.059 DBMET01574 | DBMET01574 | |
| 0.015 | 0.027 | 0.032 | Corticosteroid-like | 0.02 0.017 DBMET01573 0.032 0.006 DBMET01574 | DBMET01574 | |
| 0.082 | 0.095 | 0.099 | Bile acid receptor antagonist | 0.099 0.052 DBMET01573 0.099 0.052 DBMET01574 | DBMET01574 | |
| 0.036 | 0.049 | 0.062 | Mannosidase inhibitor | 0.05 0.025 DBMET01573 0.062 0.016 DBMET01574 | DBMET01574 | |
| 0.057 | 0.07 | 0.066 | Prolactin release inhibitor | 0.066 0.031 DBMET01574 | DBMET01574 | |
| 0.075 | 0.092 | 0.136 | Bronchodilator | 0.136 0.037 DBMET01573 0.093 0.071 DBMET01574 | DBMET01573 | |
| 0.144 | 0.165 | 0.188 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.158 0.13 DBMET01573 0.188 0.083 DBMET01574 | DBMET01574 | |
| 0.005 | 0.026 | 0.01 | Thromboxane agonist | 0.01 0.009 DBMET01573 0.01 0.009 DBMET01574 | DBMET01574 | |
| 0.064 | 0.086 | 0.076 | Estrogen receptor alpha antagonist | 0.074 0.06 DBMET01573 0.076 0.056 DBMET01574 | DBMET01574 | |
| 0.004 | 0.029 | 0.018 | Antibiotic Macrolide-like | 0.018 0.007 DBMET01573 | DBMET01573 | |
| 0.145 | 0.171 | 0.185 | Interleukin agonist | 0.185 0.135 DBMET01573 | DBMET01573 | |
| 0.03 | 0.057 | 0.048 | Glucose-6-phosphate dehydrogenase inhibitor | 0.048 0.013 DBMET01573 0.035 0.033 DBMET01574 | DBMET01573 | |
| 0.02 | 0.059 | 0.037 | Farnesoid X receptor agonist | 0.037 0.028 DBMET01573 0.036 0.028 DBMET01574 | DBMET01573 | |
| 0.07 | 0.123 | 0.091 | T cell inhibitor | 0.091 0.036 DBMET01573 | DBMET01573 | |
| 0.004 | 0.061 | 0.029 | Glucocorticoid agonist | 0.029 0.006 DBMET01574 | DBMET01574 | |
| 0.117 | 0.176 | 0.14 | Non-steroidal antiinflammatory agent | 0.14 0.13 DBMET01574 | DBMET01574 | |
| 0.023 | 0.089 | 0.039 | Liver X receptor alpha agonist | 0.039 0.031 DBMET01573 | DBMET01573 | |
| 0.029 | 0.11 | 0.086 | Acetyl-CoA transferase inhibitor | 0.086 0.018 DBMET01573 | DBMET01573 | |
| 0.083 | 0.184 | 0.304 | Neurotrophic factor | 0.304 0.008 DBMET01573 | DBMET01573 | |
| 0.049 | 0.151 | 0.146 | Antineoplastic alkaloid | 0.096 0.05 DBMET01573 0.146 0.029 DBMET01574 | DBMET01574 | |
| 0.021 | 0.127 | 0.036 | Acetyl-CoA transferase 1 inhibitor | 0.036 0.035 DBMET01573 | DBMET01573 | |
| 0.009 | 0.121 | 0.145 | Motilin receptor agonist | 0.145 0.004 DBMET01573 | DBMET01573 | |
| 0.052 | 0.165 | 0.196 | Topoisomerase II inhibitor | 0.196 0.034 DBMET01573 | DBMET01573 | |
| 0.012 | 0.13 | 0.033 | HMG CoA reductase inhibitor | 0.033 0.026 DBMET01573 0.032 0.028 DBMET01574 | DBMET01573 | |
| 0.095 | 0.22 | 0.286 | Hypolipemic | 0.286 0.053 DBMET01573 0.179 0.11 DBMET01574 | DBMET01573 | |
| 0.1 | 0.228 | 0.262 | Free radical scavenger | 0.262 0.064 DBMET01574 | DBMET01574 | |
| 0.009 | 0.138 | 0.043 | Glucocorticoid antagonist | 0.043 0.018 DBMET01574 | DBMET01574 | |
| 0.02 | 0.149 | 0.035 | Antibiotic Aminoglycoside-like | 0.035 0.027 DBMET01573 0.035 0.027 DBMET01574 | DBMET01574 | |
| 0.129 | 0.266 | 0.238 | Peptidyltransferase inhibitor | 0.238 0.06 DBMET01573 0.238 0.06 DBMET01574 | DBMET01574 | |
| 0.057 | 0.195 | 0.195 | Nav1.1 sodium channel blocker | 0.195 0.02 DBMET01573 | DBMET01573 | |
| 0.031 | 0.224 | 0.17 | Topoisomerase I inhibitor | 0.17 0.034 DBMET01573 0.111 0.061 DBMET01574 | DBMET01573 | |
| 0.125 | 0.352 | 0.22 | Caspase 3 stimulant | 0.22 0.143 DBMET01573 0.209 0.157 DBMET01574 | DBMET01573 | |
| 0.012 | 0.26 | 0.038 | Motilin receptor antagonist | 0.038 0.008 DBMET01573 | DBMET01573 | |
| 0.045 | 0.32 | 0.107 | Estrogen antagonist | 0.107 0.081 DBMET01574 | DBMET01574 | |
| 0.08 | 0.378 | 0.394 | Immunosuppressant | 0.394 0.065 DBMET01573 0.344 0.09 DBMET01574 | DBMET01573 | |
| 0.07 | 0.455 | 0.311 | Antiobesity | 0.311 0.109 DBMET01574 | DBMET01574 | |
| 0.025 | 0.529 | 0.085 | Thioredoxin reductase inhibitor | 0.085 0.049 DBMET01573 | DBMET01573 | |
| 0.079 | 0.599 | 0.213 | Interleukin 2 agonist | 0.213 0.168 DBMET01573 0.213 0.168 DBMET01574 | DBMET01574 | |
| 0.019 | 0.586 | 0.158 | Angiogenesis stimulant | 0.158 0.118 DBMET01574 | DBMET01574 | |
| 0.023 | 0.653 | 0.204 | Tumour necrosis factor alpha release inhibitor | 0.204 0.106 DBMET01574 | DBMET01574 | |
| 0.021 | 0.79 | 0.452 | Immunomodulator | 0.452 0.031 DBMET01573 | DBMET01573 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |